Current and future roles for GLP 1 Receptor Agonists in Primary Practice
Jeremy Gilbert, MD, FRCPC
Topics: Diabetes, GLP 1 RA
Details
Objectives
- Review practical approach to counselling about using GLP 1 RA for people with and without diabetes
- Discuss the evidence supporting the use of injectable and oral GLP 1 RAs based on case examples
- Explore the potential role for novel GLP 1 RAs in primary practice
Faculty
Jeremy Gilbert MD, FRCPC
Program Director, Adult Endocrinology and Metabolism
Sunnybrook Health Sciences Centre
Dr. Gilbert is heavily involved in the management, advancement and continuing medical education of Diabetes. Jeremy completed his medical degree, internal medicine training and endocrinology residency at the University of Toronto. He is an associate professor at the University of Toronto. He is the program director for adult endocrinology and metabolism at the University of Toronto. He has authored a chapter in the 2013 and 2018 Diabetes Canada Guidelines and was a member of the steering committee of the 2018 Diabetes Canada Guidelines. He is on the executive and is a national editor for the Canadian Journal of Diabetes. He is a passionate teacher and his academic interest is in undergraduate, postgraduate and continuing medical education in diabetes and endocrinology. He has received numerous awards for outstanding teaching.